TipRanks
Nektar Therapeutics (CH:NKTR)
:NKTR
Switzerland Market
NKTR
Nektar Therapeutics
RESEARCH TOOLSreports

Nektar Therapeutics (NKTR) Stock News & Sentiment

1 Followers
3 ‘Strong Buy’ High-Risk/High-Reward Stocks to Bank on for 100%+ Upside Potential
Premium
Market News
3 ‘Strong Buy’ High-Risk/High-Reward Stocks to Bank on for 100%+ Upside Potential
22d ago
TE
AADX
Buy Rating Reaffirmed on Rezpeg’s Differentiated Profile; Price Target Maintained at $151
Premium
Ratings
Buy Rating Reaffirmed on Rezpeg’s Differentiated Profile; Price Target Maintained at $151
27d ago
NKTR
Nektar shares long-term dermatology data on rezpegaldesleukin
Premium
Company Announcements
Nektar shares long-term dermatology data on rezpegaldesleukin
1M ago
8K
NKTR
Analyst Reiterates Buy on Nektar as Legal Overhang Clears, REZPEG Outlook Strengthens and $178 Price Target Remains Unchanged
Premium
Ratings
Analyst Reiterates Buy on Nektar as Legal Overhang Clears, REZPEG Outlook Strengthens and $178 Price Target Remains Unchanged
1M ago
NKTR
Nektar Wins $90 Million Verdict in Lilly Dispute
Premium
Company Announcements
Nektar Wins $90 Million Verdict in Lilly Dispute
1M ago
8K
NKTR
Nektar’s Rezpeg Trial Completion Adds a New Catalyst in Alopecia Areata
Premium
Company Announcements
Nektar’s Rezpeg Trial Completion Adds a New Catalyst in Alopecia Areata
1M ago
NKTR
Nektar Therapeutics’ Earnings Call Highlights Rezpeg Momentum
Premium
Company Announcements
Nektar Therapeutics’ Earnings Call Highlights Rezpeg Momentum
2M ago
NKTR
More CH:NKTR News >

NKTR News on the Web

Nektar selloff on trial brings ‘strong entry point,’ says BTIG
TipRanks News
Bullish
Analyst Reiterates Buy on Nektar as Legal Overhang Clears, REZPEG Outlook Strengthens and $178 Price Target Remains Unchanged
TipRanks News
Bullish
Nektar awarded $90M in Eli Lilly breach of contract case
TipRanks News
Neutral
Nektar Therapeutics Plunges as Legal and Safety Fears Mount
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Nektar Therapeutics (NKTR) and Eli Lilly & Co (LLY)
TipRanks News
Bullish
Stonepine Capital Management, LLC Buys Femasys Inc (FEMY) -- Shares Look 70% Undervalued on GF Value
GuruFocus News
Neutral
Stonepine Capital Management, LLC Expands Edesa Biotech Inc (EDSA) Stake with Strategic Add
GuruFocus News
Neutral
Stonepine Capital Management Expands CalciMedica Stake in Bold Contrarian Move
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
CH:NKTR
Sector Average
Media Buzz
This Week1 articles
Weekly Average9 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is CH:NKTR’s Media Buzz Sentiment?
1 articles about CH:NKTR were published this week. In an average week, 9 articles are published.
    What is CH:NKTR’s weekly average amount of articles?
    In an average week, 9 articles about CH:NKTR are published.
      What is CH:NKTR’s News Sentiment?
      50% of articles about CH:NKTR were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CNCCentene
        GMABGenmab
        LHLabcorp Holdings
        KIDSOrthoPediatrics
        DXCMDexcom
        Showing the stocks with the most bullish news sentiment over the past week